Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
PFE closed Tuesday's trading at $35.69 ... TTNP closed Tuesday's trading at $0.80, down 4.63%. In after-hours, the stock was up 25% to $1.00. Xenon Pharmaceuticals Inc. (XENE) has announced positive interim data from its ongoing phase …
Meanwhile, Dow component Pfizer Inc. (NYSE:PFE) helped boost the blue-chip index higher after ... at 17,832.03; the …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Pfizer Inc. (NYSE: PFE) announced today positive topline results of two Phase 3 studies of TRUMENBA® (Meningococcal Group B Vaccine). One study included approximately 3,600 healthy individuals 10 through 18 years of age, and the …
Diane Alter: The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE:AGN). Pfizer Inc. (NYSE:PFE) is pushing forward with the deal despite the best wishes of the U.S. …
Pfizer Inc. (NYSE:PFE) is expected to focus on the development of new ... likely speeding up its final testing and …
Pfizer (NYSE: PFE) positive top-line results of a Phase 2 study of TRUMENBA (Meningococcal Group B Vaccine) co-administered with FDA-approved, routine meningococcal (groups A, C, Y and W) (MCV4) and single-dose tetanus, …